NOVAGOLD Provides Update on Donlin Gold Infrastructure and Energy Supply With Initial Glenfarne Letter of IntentVANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or the “Company”) (NYSE American, TSX: NG) announces that Donlin Gold LLC (“Donlin Gold”), which is owned 60% by NOVAGOLD and 40% by Paulson Advisers LLC (“Paulson”), and Glenfarne Alaska LNG, LLC (“Glenfarne”), majority owner and developer of the Alaska LNG Project (“Alaska LNG”), signed a non-binding Letter of Intent (LOI) for natural gas supply from the Alaska LNG Pipeline and the development of the infrastructure needed to deliver the gas and power the proposed mine.
THCA Flower Stats 2026: Exhale Wellness Reports Sales Volume and Buyer Usage Trends Across 10 THCA Flower StrainsA 2026 industry report examining THCA flower sales activity, strain demand, and self-reported buyer usage trends based on internal data from Exhale Wellness.
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference Saint Herblain (France), January 09, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that members of its management team will meet one-on-one with existing shareholders and hold meetings with other institutional specialist investors during the 44th Annual J.P. Morgan Healthcare Conference, January 12-14, 2026, in San Francisco.
Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public OfferingBOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the pricing of an underwritten public offering of 11,125,000 shares of its common stock at a public offering price of $24.00 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 1,375,000 shares of common stock at a public offering price of $23.9999 per pre-funded warrant, which represents the per share public offering price of each share of common stock less the $0.0001 per share exercise price for each pre-funded warrant. Monte Rosa also granted the underwriters a 30-day option to purchase up to an additional 1,875,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Monte Rosa from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $300 million, excluding any exercise of the underwriters’ option to purchase additional shares. All of the shares and pre-funded warrants in the offering are to be sold by Monte Rosa. The offering is expected to close on or about January 12, 2026, subject to satisfaction of customary closing conditions.
Aktis Oncology Announces Pricing of its Upsized Initial Public OfferingBOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies, today announced the pricing of its upsized initial public offering of 17,650,000 shares of its common stock at a price to the public of $18.00 per share. In addition, Aktis has granted the underwriters a 30-day option to purchase up to an additional 2,647,500 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Aktis, are expected to be approximately $318.0 million, excluding any exercise of the underwriters’ option to purchase additional shares. All of the shares of common stock are being offered by Aktis. Aktis’ common stock is expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “AKTS” on January 9, 2026. The offering is expected to close on January 12, 2026, subject to satisfaction of customary closing conditions.
Alchera X Advances Industry Leadership with Executive Feature in Leading Technology Publication during CES 2026 in Las VegasLOS ANGELES, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Alchera X (AX), a global leader in AI-powered facial recognition and computer vision solutions, is beginning 2026 on a strong trajectory, marked by high-profile national media coverage, executive leadership recognition from the Los Angeles Times, and strategic global engagement across the artificial intelligence ecosystem.
Soren Acquisition Corp. Announces Closing of $253 Million Initial Public OfferingMiami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Soren Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,300,000 units, which includes 3,300,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $253,000,000.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.Taipei, Taiwan, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Semilux International Ltd. (the “Company”) received a letter (the “MVLS Deficiency Notice”) from the listing qualifications department staff (the “Staff”) of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that that from November 13, 2025 to December 30, 2025, the Company’s Market Value of Listed Securities (“MVLS”) was below the minimum of $35 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”).
Lafayette Digital Acquisition Corp. I Announces Pricing of $250,000,000 Initial Public OfferingMiami, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Lafayette Digital Acquisition Corp. I (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 25,000,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company’s initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share, subject to adjustments. The units are expected to trade on The Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “ZKPU” beginning January 9, 2026. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “ZKP” and “ZKPW,” respectively.
Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiarySAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, filed a partial motion to dismiss Tesaro’s anticipatory breach of contract claim in Delaware Chancery Court related to pending litigation between Anaptys, GSK, and TESARO, Inc. (“Tesaro”) regarding their Collaboration and Exclusive License Agreement (“Collaboration Agreement”), which entitles Anaptys to receive royalties upon sales of Jemperli.
Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2025 Operating ResultsDALLAS, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (
NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the full year and fourth quarter of 2025 before market on Thursday, January 22, 2026. Executive management will host a conference call and webcast to discuss full year and fourth quarter 2025 operating results on Thursday, January 22, 2026, at 9:00 a.m. EDT.
Mackenzie Realty Capital Announces the Creation of Mackenzie Apartment Communities, Inc. as a Stand-alone CompanyORINDA, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mackenzie Realty Capital, Inc. (“MKZR”) today announced that as of January 1, 2026, its multi-family assets and development property have been contributed to a newly created entity, MacKenzie Apartment Communities, Inc. (“MAC”). MAC is a separate, stand-alone company focused on developing and owning multi-family properties on the West Coast. MAC is currently 100% owned by MKZR.
Algoma Steel Provides Guidance for the Fourth Quarter of 2025SAULT STE. MARIE, Ontario, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, today provided guidance for its quarter ended December 31, 2025. Unless otherwise specified, all amounts are in Canadian dollars.
Clearway Energy Operating LLC, a Subsidiary of Clearway Energy, Inc., Announces Pricing of Upsized Offering of $600 Million of Senior NotesPRINCETON, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Clearway Energy Operating LLC (“Clearway Operating”), a subsidiary of Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Clearway Energy”), has priced its offering of $600 million in aggregate principal amount of 5.750% senior notes due 2034 (the “New Notes”) at a purchase price of 100% of their face value. Clearway Operating increased the size of the offering to $600 million from the previously announced $500 million. The New Notes will be senior unsecured obligations of Clearway Operating and will be guaranteed by Clearway Energy LLC, Clearway Operating’s parent company, and by each of Clearway Operating’s wholly owned current and future subsidiaries that guarantees indebtedness under its credit agreement.
Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing InvestigationsNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Soleno Therapeutics, Inc. (
NASDAQ:SLNO), AVITA Medical, Inc. (
NASDAQ:RCEL), and Coty, Inc. (
NYSE:COTY). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
Aptera Motors Appoints Automotive Industry Veteran Tony Kirton as Chairman of the Board of DirectorsCARLSBAD, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (
NASDAQ: SEV), a solar mobility company advancing ultra-efficient transportation, today announced that Tony Kirton has been appointed Chairman of the Board of Directors.
Prospect Capital Announces Annual Meeting UpdateNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (
NASDAQ: PSEC) (“Prospect”, “our”, or “we”) today announced that it held its adjourned annual meeting of stockholders (the “Annual Meeting”) on January 8, 2026. The proposals that were considered at the Annual Meeting are described in detail in the Company’s definitive proxy statement for the Annual Meeting as filed with the Securities and Exchange Commission on September 18, 2025 (the “Proxy”). As of September 17, 2025, there were 465,087,009 shares of the Company's common stock outstanding, 26,232,644 shares of the Company’s 5.50% Series A1 Preferred Stock outstanding, 163,000 shares of the Company’s 5.50% Series A2 Preferred Stock outstanding, 5,251,157 shares of the Company’s 5.35% Series A Fixed Rate Cumulative Perpetual Preferred Stock outstanding, 1,062,493 shares of the Company’s 5.50% Series M1 Preferred Stock outstanding, 23,857,330 shares of the Company’s 6.50% Series A3 Preferred Stock outstanding, 2,154,155 shares of the Company’s 6.50% Series M3 Preferred Stock outstanding, 6,961,866 shares of the Company’s Floating Rate Series A4 Preferred Stock outstanding, 2,208,807 shares of the Company’s Floating Rate Series M4 Preferred Stock outstanding, 2,143,366 shares of the Company’s 7.50% Series A5 Preferred Stock outstanding and 546,053 shares of the Company’s 7.50% Series M5 Preferred Stock outstanding. Each share of common stock is entitled to one vote on each matter to be voted on by holders of the common stock at the Annual Meeting, and each share of preferred stock is entitled to one vote on each matter to be voted on by holders of the preferred stock at the Annual Meeting. To afford additional time to solicit stockholder votes for the proposal found in the Proxy, the Annual Meeting has been adjourned until January 15, 2026, at 4:00 p.m., Eastern Time, at www.virtualshareholdermeeting.com/PSEC2025.
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive AppointmentsBOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (
NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation–inhibition imbalance, today announced the appointment of Jeffrey B. Kindler and Stuart Arbuckle to its board of directors, and the promotions of Megan Sniecinski to Chief Operating Officer and Dr. Steven Petrou to President of Research & Development.
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the FirmNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Regencell Bioscience Holdings Limited (
NASDAQ:RGC) and Camping World Holdings, Inc. (
NYSE:CWH). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided.
BELLRING BRANDS INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Urges BRBR Investors to Contact the Firm Regarding Ongoing InvestigationBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BellRing Brands (BRBR) To Contact Him Directly To Discuss Their Options
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026GAITHERSBURG, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (
NYSE: EBS) announced it has received a delivery order valued at up to $21.5 million from the U.S. Department of War to supply BioThrax® (Anthrax Vaccine Adsorbed) in 2026. This order is under Emergent’s existing indefinite-delivery/indefinite-quantity (IDIQ) contract (W911SR24D0001), led by the Capability Program Executive Chemical, Biological, Radiological and Nuclear Defense (CPE CBRND), previously the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), in collaboration with the Defense Health Agency.
Cellectis Announces 2026 Strategy and CatalystsNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today outlined its strategic priorities and key catalysts expected for 2026.
Navient announces changes to leadership structure aligned to business strategyHERNDON, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) announced today the following changes in its leadership structure to better align with its business strategy.
reAlpha to Host Live X Spaces Fireside Chat on Real-World AI Applications in Mortgage and Real EstateLive executive conversation on practical AI use in mortgage and real estate, focused on real-world application and thoughtful adoption
Verisk Announces Sale of its Marketing Solutions Business to ActiveProspectTransaction reinforces Verisk’s focus on global insurance and capital allocation discipline
Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2025 Update- Acquired 216 Properties for $123 Million in 2025 -- Full Year 2025 Weighted Average Cash Capitalization Rate of 7.7% -- 89% of Debt Outstanding Set to Fixed Rates -- No Debt Maturities Until 2028 -
Enact to Host Fourth Quarter 2025 Earnings Call February 4thRALEIGH, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 3, 2026. Enact will host a conference call to review fourth quarter 2025 financial results on February 4, 2026 at 8:00 a.m. (ET).
AXIS Capital to Release Fourth Quarter Financial Results on January 28, 2026PEMBROKE, Bermuda, Jan. 08, 2026 (GLOBE NEWSWIRE) -- AXIS Capital Holdings Limited (“AXIS Capital” or the “Company”) (
NYSE: AXS) today announced that it expects to release financial results for the fourth quarter ended December 31, 2025 on Wednesday, January 28, 2026 after the close of the financial markets.
Kite Realty Group to Report Fourth Quarter 2025 Financial Results on February 17, 2026INDIANAPOLIS, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (
NYSE: KRG) announced today that it will release financial results for the quarter ending December 31, 2025, before the market opens on Tuesday, February 17, 2026. KRG will conduct a conference call to discuss its financial results on Tuesday, February 17, 2026 at 11:00 a.m. Eastern Time.
BGIN BLOCKCHAIN LIMITED Announces Share Purchases by Chairman and Independent DirectorSINGAPORE, Jan. 09, 2026 (GLOBE NEWSWIRE) -- BGIN BLOCKCHAIN LIMITED (“BGIN” or the “Company”; NASDAQ: BGIN), a digital asset technology company with proprietary cryptocurrency mining technologies and a manufacturer of cryptocurrency mining hardware, today announced that the chairman of its board of directors and co-founder of the Company, Oisin Li, and its independent director, Paul Tsang, had purchased additional Class A ordinary shares of the Company in the open market.
TransUnion’s 2026 Mortgage Pricing Goes Live – Prioritizing Lower Costs for HomebuyersCHICAGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- TransUnion’s (
NYSE:TRU) revised mortgage pricing model, which was announced Oct 17, 2025, went live last week. At the center of this new model is VantageScore® 4.0, which delivers three critical benefits:
35th Butter Sculpture Unveiled: “A Toast to Our Nation’s 250th Anniversary: Inspired by Founders. Grown by Farmers.”HARRISBURG, Pa., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Let’s raise a glass of milk to 250 years of American history—and to Pennsylvania’s enduring dairy legacy.
Cemtrex Completes Acquisition of Invocon, Launches Aerospace & Defense Segment and Expands Participation in Missile Defense ModernizationHauppauge, NY, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cemtrex, Inc. (Nasdaq: CETX), a diversified industrial and technology company, today announced the completion of its acquisition of Invocon, Inc., a Texas based aerospace and defense engineering firm. The closing follows recent operational momentum across the company and marks the formal launch of Cemtrex’s Aerospace & Defense segment, anchored by a profitable, mission critical platform with long-standing U.S. government and prime contractor relationships.
LPL Financial Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference CallSAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), the parent corporation of LPL Financial LLC, announced today it will report fourth quarter and full year financial results after the market closes on Thursday, January 29. The Company will host a conference call to discuss its results at 5 p.m. ET the same day.The conference call will be accessible and available for replay at investor.lpl.com/events.
Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2026 on Thursday, January 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Itron to Announce Fourth Quarter and Full Year 2025 Results on Feb. 17, 2026LIBERTY LAKE, Wash., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Itron, Inc. (
NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced today that it will release financial results for the fourth quarter and full year ended Dec. 31, 2025 at 8:30 a.m. EST on Tuesday, Feb. 17, 2026. Itron management will host a conference call at 10:00 a.m. EST to discuss the results.
Cipher Mining Announces Participation in Upcoming Investor and Industry ConferencesNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (
NASDAQ: CIFR) (“Cipher” or the “Company”), a leader in the development of industrial-scale data centers, today announced its participation in several upcoming industry conferences. Cipher’s CEO, Tyler Page, may be featured in various discussions highlighting the Company’s recent developments and growth strategy. If the presentation will be webcast, a link to such webcast will be posted on the Company’s website at https://investors.ciphermining.com, as well as on Cipher’s X and LinkedIn platforms ahead of each event.Details of the Events:
Astera Labs Announces Conference Call to Review Fourth Quarter 2025 Financial ResultsSANTA CLARA, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced that it will release its financial results for the fourth quarter 2025 after the close of market on Tuesday, Feb. 10, 2026. Astera Labs will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 OutlookPhase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ TechnologyPONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced the successful completion of the first case utilizing its Lapiplasty® Lightning™ technology.
Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal OfficerSOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Mark A. Wilson as Chief Legal Officer. Mr. Wilson is an accomplished pharmaceutical and biotech executive with more than 25 years of experience across intellectual property, corporate legal, strategic collaborations and corporate governance matters.
The Vita Coco Company Appoints Shelley Broader to Board of DirectorsNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (
NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today announced that Shelley Broader was appointed as a Class II member of the Board of Directors (the “Board”).
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key MetricsIRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, unaudited topline financial results and key metrics for the quarter ended December 31, 2025.
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues-- Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years--
DeFi Development Corp. Chief Strategy Officer to Speak at Needham’s 28th Annual Growth ConferenceBOCA RATON, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that Chief Strategy Officer Daniel Kang will be speaking at Needham’s 28th Annual Growth Conference on Wednesday, January 14, 2026, at 12:45 p.m. Eastern Time.
Legence Announces Full Exercise and Closing of Over-allotment OptionSAN JOSE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Legence Corp. (Nasdaq: LGN) (“Legence”) today announced that the underwriters of the previously announced upsized secondary underwritten public offering (the “offering”) of 8,402,178 shares of its Class A common stock (“Common Stock”) by selling stockholders affiliated with Blackstone Inc. (the “Selling Stockholders”) have fully exercised their option to purchase an additional 1,260,326 shares of Common Stock at a price to the public of $45.00 per share. The exercise of the underwriters’ option closed on January 8, 2026.
ARDENT HEALTH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ardent Health, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ardent Health (ARDT) To Contact Him Directly To Discuss Their Options
Guggenheim Investments Announces New Private Debt Vehicle Backed by LGT Capital PartnersNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Guggenheim Investments (“Guggenheim”) today announced the closing of a $250 million vehicle that will invest in Guggenheim’s private debt strategy managing an existing portfolio of loans and contributing to the platform’s continued growth. The transaction was led by LGT Capital Partners alongside investments from other limited partners.
VinceTrust Announces 2026 Expansion of Its Intelligent Digital Asset Management PlatformCompany highlights continued development of automated cryptocurrency portfolio solutions
What Professional Locksmiths Say Homeowners Get Wrong About SecurityMISSION, Kan., Jan. 08, 2026 (GLOBE NEWSWIRE) -- (Family Features) You have locks on your doors and windows, and you make sure they’re secure before you leave the house or head to bed each night. You may even have a security system with an alarm or cameras to protect your home. Some locksmiths say that may not be enough.
MLMC and LindellTV Continue Providing the Most Solid News Coverage at the White House, on Capitol Hill, and At the Pentagon While Providing Breaking News from the U.S. and around the WorldChaska, MN, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Mike Lindell Media Corp. (MLMC) and LindellTV are in the process of unveiling major updates for 2026 as they continue leading the way in news coverage that viewers demand and that no other network provides from inside and outside the Washington, D.C. Beltway. MLMC and LindellTV have the news fully covered with Cara Castronuova at the White House, Alison Steinberg on Capitol Hill, and Heather Mullins at the Pentagon.
Valley National Bancorp to Announce Fourth Quarter 2025 EarningsNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Valley National Bancorp (
NASDAQ:VLY), the holding company for Valley National Bank, announced that it will release its fourth quarter 2025 earnings before the market opens on Thursday, January 29, 2026.
Mizuho Americas and NPower Advance Tech Career Pathways for New Yorkers Through Path2TECH: NetSAThe Path2TECH: Networking & Systems Administration program was piloted in 2025 with support from a Mizuho USA Foundation FutureReady grant.
Harris Lowry Manton LLP Files Federal Lawsuit for Georgia Man Wrongfully Imprisoned for Over Two DecadesAttorneys for Sedrick Moore, a Georgia man who spent more than 23 years in prison for crimes he did not commit, filed a federal civil rights lawsuit this month. The complaint includes allegations of multiple constitutional violations, from fabrication of evidence to coercion of witness testimony, and systemic failures by state and local law enforcement agencies.
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of FireflyFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DeFi TechnologiesFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In DeFi Technologies To Contact Him Directly To Discuss Their Options
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon healthFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options
AKC Canine Health Foundation Recognizes 2025 Leaders in Canine HealthRALEIGH, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to improving the lives of all dogs through research and discovery, is excited to announce its annual awards recognizing leaders in supporting canine health.
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GauzyFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gauzy To Contact Him Directly To Discuss Their Options
Optimove Launches Comprehensive AI Marketing Tools Hub to Power Positionless MarketingNew resource hub features curated AI tools to help marketers gain insight, create faster, and optimize independently without handoffs or delays
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of StubHubFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In StubHub To Contact Him Directly To Discuss Their Options
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SproutsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sprouts To Contact Him Directly To Discuss Their Options
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix PharmaceuticalsFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlexandriaFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alexandria To Contact Him Directly To Discuss Their Options
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of StrideFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Stride To Contact Him Directly To Discuss Their Options
